The objective of this pilot project is to assess the feasibility, acceptability, and mental health impact of OULA for women with postpartum depression (PPD).

The proposed project is a pilot two-arm randomized controlled trial (RCT), with specific aims to evaluate the feasibility and acceptability of implementing an RCT of OULA (named after Missoula, MT) for the treatment of postpartum depression, and to explore between-subject changes in postpartum depression and postpartum anxiety following 8-weeks of OULA or waitlist control.

Inclusion Criteria:

• Ages 20-39 years
• Have an infant 0-12 months old
• Self-report clearance from provider to engage in physical activity following birth
• Structured Clinical Interview for Diagnostic Statistical Manual-5-Research Version (SCID-5-RV) diagnosis of major depressive episode (MDE) with onset during pregnancy or 12 months following childbirth
• Edinburgh Postnatal Depression Scale (EPDS) score of 10 or above
• English speaking
• OULA-naïve
• If on first-line treatment for depression; antidepressant dose must be stable for 6 weeks; psychotherapy duration of treatment must be at least 4 weeks

Exclusion Criteria:

• Unable to be physically active
• Current pregnancy
• SCID-5-RV diagnosis of bipolar disorder, schizophrenia, or current substance use disorder
• Active suicidal attempt or plan identified on the SCID-5-RV
• Suicide attempt in the past 6 months
• Concurrent participation in another group dance fitness format
• No access to Internet via computer, tablet, or smart phone

Data obtained through this study may be provided to qualified researchers with academic interest in mind-body physical activity interventions for postpartum depression. Data or samples shared will be coded, with no PHI included. Approval of the request and execution of all applicable agreements (i.e. a material transfer agreement) are prerequisites to the sharing of data with the requesting party.

Data requests can be submitted starting 9 months after article publication and the data will be made accessible for up to 24 months. Extensions will be considered on a case-by-case basis

Access to trial IPD can be requested by qualified researchers engaging in independent scientific research, and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a Data Sharing Agreement (DSA).